Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

Mainz Biomed (MYNZ) reviewed its major accomplishments for the year ended December 31, 2025. “I’m extremely pleased with the achievements of our ...

HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has entered into a non-binding memorandum (the ...

We are at an inflection point in how we support science in the U.S. New York state must invest in its science institutions and workforce.

Marion Underwood resigned after two years as provost and executive vice president at Colorado State University's main campus ...

Logan Jenner, a five-year-old battling acute myeloid leukemia, found new hope through a clinical trial that used Functional Precision Medicine to guide a personalized treatment approach after standard ...

Ping An Biomedical Co., Ltd (NASDAQ:PASW) stock tumbled 31% on Friday after the company announced a strategic investment plan in Future Biotechnology Group. The b ...

Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the "Investment ...

Future FinTech a leading comprehensive financial and digital technology service provider, announced today that on January 7, 2026, its wholly-owned subsidiary, Future FinTech (Hong Kong) Limited ...

Researchers have developed a compact handheld imaging probe that could expand the clinical and research use of photoacoustic ...

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program. Shine-On ...